CD8A and neoplasm: This process promotes dendritic cells (DCs) maturation and activates CD8+ T cells and natural killer cells.[35, 36, 37, 38] ICB therapy enhances cytotoxic T‐cell levels, preventing tumor immune evasion, inhibiting distant tumor growth, and establishing long‐term immune memory.